Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweden
/
Sofia Therese Hultman
ST
Sofia Therese Hultman
Chief Executive Officer, Shire Sweden Holdings S.a r.l., Sverige filial
Upplandsgatan 6
SE
8 active roles
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
8 positions
Company
Role
Period
Ownership
Status
Shire Sweden Holdings S.a r.l., Sverige filial
CVR 5164083684
Management
Chief Executive Officer
Since 2022
—
Active
Takeda Pharma AB
CVR 5561130302
Board
Board of Directors
Since 2024
—
Active
Shire Human Genetic Therapies AB
CVR 5565911764
Board
Board of Directors
Since 2024
—
Dissolved
DuoCort Pharma AB
CVR 5567344006
Board
Board of Directors
Since 2020
—
Dissolved
ViroPharma AB
CVR 5568636350
Board
Board of Directors
Since 2020
—
Dissolved
Premacure Uppsala AB
CVR 5568754310
Board
Board of Directors
Since 2020
—
Dissolved
Ctrl Management AB
CVR 5594629874
Board
Deputy Board Member
Since 2024
—
Active
Bostadsrättsföreningen U27
CVR 7696420467
Board
Board of Directors
Since 2023
—
Active
Historical roles
2 positions
Company
Role
Period
Ownership
Status
Shire Sweden AB
CVR 5568189210
Board
Board of Directors
2020 – 2021
—
Dissolved
Ventura Markets AB
CVR 5595002709
Board
Deputy Board Member
2024 – 2025
—
Active
1 dissolved company in directorship history
Shire Sweden AB
CVR 5568189210 · Dissolved 2021 · —
Role: Board of Directors
More on Sofia Therese Hultman
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities